Analysis of Immunotherapy in ovarian cancer

dc.centroFacultad de Medicinaes_ES
dc.contributor.authorBurgos-Molina, Antonio Manuel
dc.contributor.authorAlamilla Presuel, Juan Carlos
dc.contributor.authorGonzález Vidal, Alejandro
dc.contributor.authorRuiz-Gómez, Miguel José
dc.date.accessioned2023-01-11T12:46:59Z
dc.date.available2023-01-11T12:46:59Z
dc.date.created2023
dc.date.issued2022
dc.departamentoEspecialidades Quirúrgicas, Bioquímica e Inmunología
dc.description.abstractThere are many Immunotherapy methods in ovarian cancer. Even the immune cells themselves can be part of the immunotherapy. But also at molecular level, the immunotherapy can be applied, like maintaining damage in DNA or inhibiting certain pathways. Nevertheless, there is still needed to understand the mechanism of immunotherapy.es_ES
dc.description.sponsorshipCampus de Excelencia Internacional Andalucía Tech.es_ES
dc.identifier.urihttps://hdl.handle.net/10630/25713
dc.language.isoenges_ES
dc.publisherAseicaes_ES
dc.relation.eventdate16 al 18 de Noviembre 2022es_ES
dc.relation.eventplaceSantiago de Compostela, España.es_ES
dc.relation.eventtitle18th ASEICA INTERNATIONAL CONGRESSes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectInmunoterapia - Congresoses_ES
dc.subjectCancer - Congresoses_ES
dc.subject.otherImmunotherapyes_ES
dc.subject.otherOvarian canceres_ES
dc.titleAnalysis of Immunotherapy in ovarian canceres_ES
dc.typeconference outputes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationde49c054-e443-41f5-94e9-bd9c022959e9
relation.isAuthorOfPublication52572afd-4d3c-4c34-82a7-3774888d42e1
relation.isAuthorOfPublication.latestForDiscoveryde49c054-e443-41f5-94e9-bd9c022959e9

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
14-Burgos-Molina AM -Analysis of Immunotherapy in ovarian cancer.pdf
Size:
220.31 KB
Format:
Adobe Portable Document Format
Description: